应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01609 天星医疗
已收盘 07-06 16:08:30
177.900
+5.100
+2.95%
最高
178.000
最低
167.700
成交量
3.21万
今开
171.800
昨收
172.800
日振幅
5.96%
总市值
97.54亿
流通市值
97.54亿
总股本
5,483万
成交额
560.78万
换手率
0.06%
流通股本
5,483万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
天星医疗更新2026年6月股份变动月报表,股本维持不变
公告速递 · 07-03
天星医疗更新2026年6月股份变动月报表,股本维持不变
55家公司港股通新贵即将喜迎北水流入 入通门槛或已抬升至102.67亿港元
智通财经 · 07-01
55家公司港股通新贵即将喜迎北水流入 入通门槛或已抬升至102.67亿港元
天星医疗宣布不派2025年度股息
公告速递 · 06-26
天星医疗宣布不派2025年度股息
天星医疗宣布不派2025年度股息
公告速递 · 06-05
天星医疗宣布不派2025年度股息
天星医疗更新5月股份变动月报表,股本维持稳定
公告速递 · 06-02
天星医疗更新5月股份变动月报表,股本维持稳定
天星医疗1.9亿元加码财务管理:认购北京银行与农业银行低风险理财产品,业绩比较基准最高3%
公告速递 · 05-26
天星医疗1.9亿元加码财务管理:认购北京银行与农业银行低风险理财产品,业绩比较基准最高3%
天星医疗(01609)认购北京银行1.1亿元及农业银行8000万元的理财产品
智通财经 · 05-26
天星医疗(01609)认购北京银行1.1亿元及农业银行8000万元的理财产品
异动解读 | 天星医疗盘中大跌5.27%,上市后缺乏稳价机制致股价剧烈波动
异动解读 · 05-08
异动解读 | 天星医疗盘中大跌5.27%,上市后缺乏稳价机制致股价剧烈波动
一场筹码游戏的三日推演 天星医疗(01609)从暗盘501港元到首日破位深V
智通财经 · 05-07
一场筹码游戏的三日推演 天星医疗(01609)从暗盘501港元到首日破位深V
异动解读 | 天星医疗上市首日盘中大涨181.22%,获逾7800倍超额认购引爆市场热情
异动解读 · 05-05
异动解读 | 天星医疗上市首日盘中大涨181.22%,获逾7800倍超额认购引爆市场热情
天星医疗(01609)香港公开发售获7823.13倍认购 全球发售净筹约7.584亿港元
智通财经 · 05-04
天星医疗(01609)香港公开发售获7823.13倍认购 全球发售净筹约7.584亿港元
天星医疗H股公开发售录得7,823倍超购 5月5日登陆港交所主板
公告速递 · 05-04
天星医疗H股公开发售录得7,823倍超购 5月5日登陆港交所主板
新股暗盘 | 天星医疗(01609)暗盘盘初涨逾230% 每手赚11335港元
中金财经 · 05-04
新股暗盘 | 天星医疗(01609)暗盘盘初涨逾230% 每手赚11335港元
老虎暗盘 | 天星医疗涨超400%,总市值超273亿港元
老虎资讯综合 · 05-04
老虎暗盘 | 天星医疗涨超400%,总市值超273亿港元
新股消息 | 天星医疗(01609)结束招股 孖展认购额录得5304.7亿港元 超购6393.3倍
智通财经 · 04-29
新股消息 | 天星医疗(01609)结束招股 孖展认购额录得5304.7亿港元 超购6393.3倍
新股孖展统计 | 4月24日
智通财经网 · 04-24
新股孖展统计 | 4月24日
新股招股 | 天星医疗今日起至4月29日招股,一手入场费4974.67港元
老虎资讯综合 · 04-24
新股招股 | 天星医疗今日起至4月29日招股,一手入场费4974.67港元
北京天星医疗启动全球发售,专注运动医学器械业务
公告速递 · 04-24
北京天星医疗启动全球发售,专注运动医学器械业务
创建集团控股将失去上市地位,投资者需关注后续动态
和讯网 · 2024-03-27
创建集团控股将失去上市地位,投资者需关注后续动态
联交所:创建集团(01609.HK)下月2日起除牌
阿斯达克财经 · 2024-03-27
联交所:创建集团(01609.HK)下月2日起除牌
加载更多
公司概况
公司名称:
天星医疗
所属市场:
SEHK
上市日期:
--
主营业务:
北京天星医疗股份有限公司(简称“天星医疗”)作为国产运动医学的领导者,致力于提供运动医学的整体临床解决方案,公司坐落于北京经济技术开发区,注册资本4000多万,现有员工200余人。应用于肩关节、膝关节、足/踝关节、髋关节、肘关节、手/腕关节的运动医学设备、植入物和手术器械共计300多个品规通过NMPA的批准,临床应用于国内31个省市、自治区的数千家医院。主要从事运动医学植入物、有源设备及耗材,以及手术工具的研发、生产与销售。
发行价格:
--
{"stockData":{"symbol":"01609","market":"HK","secType":"STK","nameCN":"天星医疗","latestPrice":177.9,"timestamp":1783325310521,"preClose":172.8,"halted":0,"volume":32050,"delay":0,"changeRate":0.029513888888888853,"floatShares":54831344,"shares":54831344,"eps":3.4053593639743074,"marketStatus":"已收盘","change":5.1,"latestTime":"07-06 16:08:30","open":171.8,"high":178,"low":167.7,"amount":5607792,"amplitude":0.059606,"askPrice":178,"askSize":150,"bidPrice":177,"bidSize":100,"shortable":0,"etf":0,"ttmEps":3.1914783897607224,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783387800000},"marketStatusCode":5,"adr":0,"listingDate":1777910400000,"exchange":"SEHK","adjPreClose":172.8,"openAndCloseTimeList":[[1783301400000,1783310400000],[1783314000000,1783324800000]],"volumeRatio":0.321981,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01609","defaultTab":"news","newsList":[{"id":"1164516635","title":"天星医疗更新2026年6月股份变动月报表,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1164516635","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164516635?lang=zh_cn&edition=full","pubTime":"2026-07-03 16:57","pubTimestamp":1783069075,"startTime":"0","endTime":"0","summary":"天星医疗于2026年7月3日发布2026年6月股份变动月报表。本次公告显示,截至2026年6月30日,公司法定注册股本共计约5,483.13万元,与上月持平,面值为人民币1元。报告期内,公司普通股H股的已发行股份与库藏股数量无变动。公告同时披露,在报告期内并无任何可转债、权证或其他发行协议发生变动,公司确认已遵守香港联交所《上市规则》及相关法律法规。本次月报由联合公司秘书梁晓丹正式签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647453054","title":"55家公司港股通新贵即将喜迎北水流入 入通门槛或已抬升至102.67亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647453054","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647453054?lang=zh_cn&edition=full","pubTime":"2026-07-01 10:09","pubTimestamp":1782871774,"startTime":"0","endTime":"0","summary":"核心规则:市值门槛动态调整截至2026年6月30日,港股通实际纳入门槛已升至102.67亿,剔除门槛达66.89亿。这一指标直接决定了个股在指数中的权重与港股通资格。对于不同上市时长的公司,要求有所不同:对于上市公司而言,维持日均万五左右的换手率是保住港股通资格的关键。数据截止日为每年的6月30日和12月31日,这也是上市公司\"冲关\"港股通的关键时间窗口。","market":"hk","thumbnail":"https://static.tigerbbs.com/0cf777090175126e4590c3b8afdfe41e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0cf777090175126e4590c3b8afdfe41e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461288.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02672","07666","00100","00863","06658","03355","00068","01779","02616","03310","01081","03625","06106","07688","01236","01191","00600","00376","00412","01021","01133","02553","02272","02729","03388","BK4585","06872","02696","01879","02670","01866","07630","06675","01956","02723","01392","BK4588","02335","01672","01511","01651","02726","03661","02632","03887","01286","09637","06636","01440","09630","00340","02142","03277","06938","02526","01609","06656"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1134629277","title":"天星医疗宣布不派2025年度股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1134629277","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134629277?lang=zh_cn&edition=full","pubTime":"2026-06-26 20:06","pubTimestamp":1782475583,"startTime":"0","endTime":"0","summary":"天星医疗(01609)于6月26日举行年度股东会,审议通过了2025年度利润分配方案。根据决议,公司截至2025年12月31日止年度将不进行利润分配,意味着股东无法获得当期股息。\n此次股东会还审议了董事会工作报告、财务决算报告、续聘审计机构等多项议案,并批准撤销监事会、修订公司章程及议事规则等特别决议案。前述议案均获高比例赞成票通过,其中涉及不派息的利润分配方案以100%赞成票批准。\n公司未披露不派息的具体原因,投资者需留意后续盈利及派息政策变化。天星医疗主要从事运动医学相关业务,此前未有公开的派息记录。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"天星医疗宣布不派2025年度股息","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173127576","title":"天星医疗宣布不派2025年度股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1173127576","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173127576?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:22","pubTimestamp":1780651325,"startTime":"0","endTime":"0","summary":"天星医疗(01609)发布公告,董事会不建议就截至2025年12月31日止年度派发股息,即2025年度将不进行任何股息分派。该事项尚需提交年度股东会审议。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"天星医疗宣布不派2025年度股息","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162211496","title":"天星医疗更新5月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1162211496","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162211496?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:06","pubTimestamp":1780391201,"startTime":"0","endTime":"0","summary":"北京天星医疗股份有限公司(股票代码:01609)于2026年6月2日发布截至2026年5月31日的股份变动月报表。公告显示,公司本月已发行股份总数及注册股本均与上个月保持一致。\n本次报告期内,普通股H股维持在54,831,344股,注册股本为人民币54,831,344元,每股面值人民币1元。公告列明,公司当月并未进行新的股份发行、购回、注销或库藏股操作,股份期权、权证及可换股票据也无新增或变动,股本整体保持不变。\n公告同时提及,公司满足香港联交所主板上市规则关于最低公眾持股量的相关要求。天星医疗确认已遵守香港联交所《上市规则》及其他适用法律规定。\n该公告由联席公司秘书梁晓丹签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182065616","title":"天星医疗1.9亿元加码财务管理:认购北京银行与农业银行低风险理财产品,业绩比较基准最高3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182065616","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182065616?lang=zh_cn&edition=full","pubTime":"2026-05-26 20:31","pubTimestamp":1779798675,"startTime":"0","endTime":"0","summary":"北京天星医疗股份有限公司5月26日披露,为提高闲置资金使用效率,公司于5月11日及5月26日分别认购北京银行、农业银行发行的两款低风险理财产品,总本金1.9亿元人民币。截至公告日,天星医疗为中国本土运动医学植入物与器械领域的龙头企业;农业银行及北京银行均为在沪港上市的商业银行,与天星医疗及其关连人士保持独立。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638514772","title":"天星医疗(01609)认购北京银行1.1亿元及农业银行8000万元的理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2638514772","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638514772?lang=zh_cn&edition=full","pubTime":"2026-05-26 20:27","pubTimestamp":1779798469,"startTime":"0","endTime":"0","summary":"智通财经APP讯,天星医疗(01609)发布公告,公司已分别认购由北京银行及农业银行分别发售的两项理财产品。于2026年5月11日,公司以自有资金认购北京银行发售的本金额人民币1.1亿元的理财产品。于2026年5月26日,公司以自有资金认购农业银行发售的本金额人民币8000万元的理财产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446213.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1497733557.USD","LU1522347837.USD","BK1521","BK0015","SG9999006597.SGD","BK1231","LU1813983027.USD","BK0188","LU1064131003.USD","LU1634259557.SGD","LU0287142896.SGD","BK0086","BK0187","BK0183","LU0173614495.USD","LU2328871848.SGD","BK1100","SG9999001051.SGD","LU2039709279.SGD","LU1328277881.USD","LU1064130708.USD","BK1560","01288","LU1634259391.SGD","SG9999001069.SGD","601169","SG9999001226.SGD","BK0278","03143","SGXZ49509284.SGD","01609","LU1969619763.USD","BK0175","LU0314109678.HKD","BK0012","BK0028","SGXZ81163826.USD","601288","LU1497733631.SGD","BK1148","LU1328615791.USD","LU2148510915.USD","SGXZ90724238.SGD","LU1497734951.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167676480","title":"异动解读 | 天星医疗盘中大跌5.27%,上市后缺乏稳价机制致股价剧烈波动","url":"https://stock-news.laohu8.com/highlight/detail?id=1167676480","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167676480?lang=zh_cn&edition=full","pubTime":"2026-05-08 14:31","pubTimestamp":1778221875,"startTime":"0","endTime":"0","summary":"天星医疗今日盘中大跌5.27%,引起了市场的广泛关注。消息面上,天星医疗为近期上市新股,于5月5日登陆港交所,发行价98.5港元,香港公开发售获超高倍数认购。然而,该股未设置超额配售权(绿鞋机制)及稳价人,缺乏托底支撑,当抛压集中释放时市场只能依靠自发力量消化,这加剧了股价的波动幅度。作为国产最大运动医学植入物及器械提供商,天星医疗上市以来筹码博弈激烈,短期波动显著,缺乏稳价机制使得股价在交易中容易出现大幅涨跌。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633161236","title":"一场筹码游戏的三日推演 天星医疗(01609)从暗盘501港元到首日破位深V","url":"https://stock-news.laohu8.com/highlight/detail?id=2633161236","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633161236?lang=zh_cn&edition=full","pubTime":"2026-05-07 08:35","pubTimestamp":1778114155,"startTime":"0","endTime":"0","summary":"天星医疗在短短48小时内将“狂热”与“冷静”演绎得淋漓尽致。以每手50股计算,暗盘时段每手账面浮盈超过1万港元。截至收盘,股价报215港元,较发行价上涨116.5%,市值回落至118亿港元。早盘集合竞价阶段,股价以220.000港元开盘,随即遭遇空头集中打压,盘中快速下探至191.200港元,创下上市以来新低。从量能维度观察,当日成交量49.68万股,换手率0.906%,较上市首日5.91%的换手率显著回落。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01609","EWH","BK1148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171124462","title":"异动解读 | 天星医疗上市首日盘中大涨181.22%,获逾7800倍超额认购引爆市场热情","url":"https://stock-news.laohu8.com/highlight/detail?id=1171124462","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171124462?lang=zh_cn&edition=full","pubTime":"2026-05-05 09:35","pubTimestamp":1777944953,"startTime":"0","endTime":"0","summary":"天星医疗今日盘中股价大幅上涨181.22%,引起了市场的广泛关注。市场分析认为,作为中国领先的国产运动医学植入物及器械提供商,公司在细分赛道具有龙头地位,叠加发行估值具备吸引力,共同推动了上市首日股价的强劲表现。公开资料显示,天星医疗专注于运动医学整体解决方案,根据灼识咨询数据,按2024年销售收入计,公司为中国第四大、同时也是国产第一大运动医学植入物及器械供应商。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632951212","title":"天星医疗(01609)香港公开发售获7823.13倍认购 全球发售净筹约7.584亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632951212","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632951212?lang=zh_cn&edition=full","pubTime":"2026-05-04 22:59","pubTimestamp":1777906791,"startTime":"0","endTime":"0","summary":"智通财经APP讯,天星医疗(01609)公布配发结果,公司全球发售842.19万股H股,香港公开发售占10%,国际发售占90%。每股发售价98.5港元,全球发售净筹约7.584亿港元。每手50股,预期H股将于2026年5月5日(星期二)上午九时正在联交所开始买卖。其中,香港公开发售获7823.13倍认购,国际发售获10.41倍认购。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437959.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01609","BK1148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101913752","title":"天星医疗H股公开发售录得7,823倍超购 5月5日登陆港交所主板","url":"https://stock-news.laohu8.com/highlight/detail?id=1101913752","media":"公告速递","labels":["shareholding","corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101913752?lang=zh_cn&edition=full","pubTime":"2026-05-04 22:55","pubTimestamp":1777906543,"startTime":"0","endTime":"0","summary":"北京天星医疗股份有限公司完成全球发售并公布配售结果。本次共发行8,421,850股H股,发售价每股98.50港元,预计募资总额约8.30亿元,扣除约7,120万港元发行费用后,募资净额约7.58亿元。公司H股将于2026年5月5日(星期二)在香港联合交易所主板挂牌交易,每手买卖单位为50股。香港公开发售接获300,735份有效申请,认购倍数高达7,823.13倍,显著超额认购。本次发行引入4名基石投资者,合计认购2,922,900股H股,占本次发售股份的34.70%,占上市后总股本约5.34%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632194931","title":"新股暗盘 | 天星医疗(01609)暗盘盘初涨逾230% 每手赚11335港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632194931","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632194931?lang=zh_cn&edition=full","pubTime":"2026-05-04 17:17","pubTimestamp":1777886225,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,天星医疗(01609)将于5月5日(周二)在香港挂牌。截至发稿,利弗莫尔证券暗盘交易显示报价325.20港元,较招股价98.50港元上涨230.15%,每手50股,不计手续费,每手赚11335港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260504/32200048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01609","EWH","BK1148"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193897323","title":"老虎暗盘 | 天星医疗涨超400%,总市值超273亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193897323","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193897323?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:15","pubTimestamp":1777882528,"startTime":"0","endTime":"0","summary":"5月4日,“中国医疗器械生产商”$天星医疗(01609)$暗盘涨超400%,总市值超273亿港元,每股定价98.50港元,每手50股;将于5月5日(周二)正式在港交所挂牌交易。公司是一家立足中国的医疗器械公司,专注于运动医学临床解决方案。据灼识谘询数据,按2024年销售收入计,公司是中国第四大运动医学植入物及器械提供商,市场份额约占中国运动医学植入物及器械市场的6.5%,也是最大的国产运动医学植入物及器械提供商。依托自主研发的植入物、有源设备、相关耗材及手术工具,公司提供肩袖、韧带、半月板等软组织损伤治疗,也提供运动康复及预防的全方位解决方案。","market":"hk","thumbnail":"https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631766564","title":"新股消息 | 天星医疗(01609)结束招股 孖展认购额录得5304.7亿港元 超购6393.3倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2631766564","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631766564?lang=zh_cn&edition=full","pubTime":"2026-04-29 15:39","pubTimestamp":1777448388,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,运动医学医疗器械供应商天星医疗于4月24日至4月29日招股,最新已结束招股。根据市场消息,截至4月29日中午,天星医疗已获5304.7亿港元孖展认购,以公开发售集资额8296万港元计,超购6393.3倍。天星医疗计划发行842.2万股H股,一成于香港作公开发售,发售价为每股98.5港元,集资8.3亿港元。招股书显示,天星医疗是一家立足中国的医疗器械公司,专注于运动医学临床解决方案。截至2025年12月31日,累计产品销量超200万件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436096.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","01609","BK1148"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2629084951","title":"新股孖展统计 | 4月24日","url":"https://stock-news.laohu8.com/highlight/detail?id=2629084951","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629084951?lang=zh_cn&edition=full","pubTime":"2026-04-24 19:43","pubTimestamp":1777031033,"startTime":"0","endTime":"0","summary":"天星医疗(01609)、商米科技(06810)正在招股中。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260424/20260424194418_26457.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260424/20260424194418_26457.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01609","BK1148","06810"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179248654","title":"新股招股 | 天星医疗今日起至4月29日招股,一手入场费4974.67港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179248654","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179248654?lang=zh_cn&edition=full","pubTime":"2026-04-24 08:54","pubTimestamp":1776992046,"startTime":"0","endTime":"0","summary":"$天星医疗$ 今日至4月29日招股,拟全球发售842.185万股H股,香港公开发售占10%,国际发售占90%。每股发售股份98.50港元,每手50股,一手入场费4974.67港元,预期股份将于2026年5月5日(星期二)上午九时正开始在联交所买卖。约25.0%将用于商业化、销售及市场推广活动,以巩固公司在中国的领先地位并建立全球市场存在及品牌形象。","market":"us","thumbnail":"https://community-static.tradeup.com/news/b85fee256ef052cf88ac937d1959d694","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b85fee256ef052cf88ac937d1959d694"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3430ee0e05254278b5a3da84a7b77b4c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1125838440","title":"北京天星医疗启动全球发售,专注运动医学器械业务","url":"https://stock-news.laohu8.com/highlight/detail?id=1125838440","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125838440?lang=zh_cn&edition=full","pubTime":"2026-04-24 06:20","pubTimestamp":1776982851,"startTime":"0","endTime":"0","summary":"北京天星医疗股份有限公司是一家主要面向运动医学临床解决方案的医疗器械企业,通过植入物、手术设备及相关耗材等核心产品,为关节、韧带和软组织损伤等场景提供诊疗和康复支持。公司在运动医学器械领域的业务涵盖植入物及相应手术设备、耗材等,并持续投入研发与产品升级。本次全球发售所得款项将主要用于扩大产能、增强产品竞争力及加强推广,进一步巩固公司在运动医学器械市场的地位,同时维持营运资金流动性。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"北京天星医疗启动全球发售,专注运动医学器械业务","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01609"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2422917002","title":"创建集团控股将失去上市地位,投资者需关注后续动态","url":"https://stock-news.laohu8.com/highlight/detail?id=2422917002","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422917002?lang=zh_cn&edition=full","pubTime":"2024-03-27 23:32","pubTimestamp":1711553550,"startTime":"0","endTime":"0","summary":"对于二级市场投资者而言,这无疑是一条备受关注的财经新闻。创建集团控股作为一家在香港联交所上市的公司,其上市地位的取消将直接影响到投资者的投资决策。这一消息的公布引发了市场的广泛关注。创建集团控股失去上市地位的消息给我们带来了一个重要的启示:投资者在进行投资时,需要全面考虑公司的经营状况和财务情况,并及时关注市场的动态变化。只有这样,才能够做出明智的投资决策,保护自己的投资利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280001278b6a3be9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280001278b6a3be9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1148","01609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2422952737","title":"联交所:创建集团(01609.HK)下月2日起除牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2422952737","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422952737?lang=zh_cn&edition=full","pubTime":"2024-03-27 17:05","pubTimestamp":1711530300,"startTime":"0","endTime":"0","summary":"联交所宣布,由下周二(4月2日)上午9时起,创建集团(01609.HK) 的上市地位将根据《上市规则》第6.01A(1)条予以取消。(sl/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190702160157314_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190702160157314_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337742/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337742/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01609","BK1148"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.starsportmed.com/","stockEarnings":[{"period":"1week","weight":0.152},{"period":"1month","weight":-0.0967},{"period":"3month","weight":0.7543},{"period":"ytd","weight":0.7543}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":-0.0891},{"period":"3month","weight":-0.0703},{"period":"6month","weight":-0.1135},{"period":"1year","weight":-0.0299},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京天星医疗股份有限公司(简称“天星医疗”)作为国产运动医学的领导者,致力于提供运动医学的整体临床解决方案,公司坐落于北京经济技术开发区,注册资本4000多万,现有员工200余人。应用于肩关节、膝关节、足/踝关节、髋关节、肘关节、手/腕关节的运动医学设备、植入物和手术器械共计300多个品规通过NMPA的批准,临床应用于国内31个省市、自治区的数千家医院。主要从事运动医学植入物、有源设备及耗材,以及手术工具的研发、生产与销售。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.121197},{"month":2,"riseRate":0.5,"avgChangeRate":0.06192},{"month":3,"riseRate":0.428571,"avgChangeRate":0.034993},{"month":4,"riseRate":0.5,"avgChangeRate":-0.011524},{"month":5,"riseRate":0.5,"avgChangeRate":0.066004},{"month":6,"riseRate":0.2,"avgChangeRate":-0.212662},{"month":7,"riseRate":0.4,"avgChangeRate":0.059988},{"month":8,"riseRate":0.4,"avgChangeRate":0.05496},{"month":9,"riseRate":0.4,"avgChangeRate":-0.011761},{"month":10,"riseRate":0.4,"avgChangeRate":-0.000213},{"month":11,"riseRate":0.333333,"avgChangeRate":0.179457},{"month":12,"riseRate":0.5,"avgChangeRate":0.080552}],"exchange":"SEHK","name":"天星医疗","nameEN":"STAR SPORTS MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"天星医疗(01609)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供天星医疗(01609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"天星医疗,01609,天星医疗股票,天星医疗股票老虎,天星医疗股票老虎国际,天星医疗行情,天星医疗股票行情,天星医疗股价,天星医疗股市,天星医疗股票价格,天星医疗股票交易,天星医疗股票购买,天星医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"天星医疗(01609)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供天星医疗(01609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}